|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,089.00 ILa | 0.00% |
|
+5.73% | -0.46% |
| Market Cap | 124M 0 40.9M 35.75M 32.99M 30.4M 57.31M 3.94B 58.58M 394M 155M 1.93B 154M 150M 6.64B | P/E 2024 |
24.5x | P/E 2025 | -6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 252M 0 83.03M 72.56M 66.96M 61.72M 116M 8B 119M 800M 315M 3.92B 312M 305M 13.48B | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.84x |
| Free-Float |
17.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | +5.73% | ||
| Current month | +2.16% | ||
| 1 month | +2.83% | ||
| 3 months | -8.87% | ||
| 6 months | -0.91% | ||
| Current year | -0.46% |
| 1 week | 1,006 |  | 1,106 |
| 1 month | 1,006 | | 1,165 |
| Current year | 1,006 | | 1,348 |
| 1 year | 1,006 | | 1,348 |
| 3 years | 1,006 | | 1,887 |
| 5 years | 1,006 | | 2,610 |
| 10 years | 1,006 | | 4,076 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 1993-08-23 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 46 | 2018-10-31 |
| President | 80 | 2010-06-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 64 | 2015-04-14 |
Avraham Bigger
CHM | Chairman | 79 | 2015-04-14 |
| Chairman | 82 | 2010-06-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +5.73% | -9.25% | -38.82% | 40.9M | |
| +0.01% | +4.40% | +18.54% | +104.90% | 98.51B | |
| -0.09% | -3.09% | +43.22% | +145.22% | 53.52B | |
| -0.34% | +3.90% | +4.27% | +266.25% | 23.53B | |
| -2.52% | +2.98% | -12.49% | -21.65% | 8.25B | |
| -5.82% | +2.45% | -32.81% | -32.05% | 7.79B | |
| -1.35% | +5.02% | -6.54% | -27.10% | 6.99B | |
| +2.44% | +0.89% | +26.58% | +30.99% | 6.31B | |
| +0.79% | +2.77% | -0.39% | +25.12% | 5.51B | |
| -2.29% | +2.00% | -4.49% | -6.59% | 3.76B | |
| Average | -0.92% | +2.65% | +2.66% | +44.63% | 21.42B | |
| Weighted average by Cap. | -0.36% | +2.37% | +18.60% | +112.32% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 322M 0 106M 92.52M 85.37M 78.69M 148M 10.19B 152M 1.02B 401M 4.99B 398M 389M 17.19B | 301M 0 99.05M 86.56M 79.87M 73.62M 139M 9.54B 142M 955M 375M 4.67B 372M 364M 16.08B |
| Net income | 6.21M 0 2.04M 1.78M 1.65M 1.52M 2.86M 197M 2.92M 19.68M 7.74M 96.32M 7.67M 7.5M 332M | -18.07M -0 -5.95M -5.2M -4.8M -4.42M -8.33M -573M -8.52M -57.33M -22.55M -281M -22.34M -21.85M -966M |
| Net Debt | 127M 0 41.82M 36.55M 33.72M 31.09M 58.59M 4.03B 59.89M 403M 159M 1.97B 157M 154M 6.79B | 128M 0 42.12M 36.81M 33.97M 31.31M 59.02M 4.06B 60.33M 406M 160M 1.99B 158M 155M 6.84B |
Employees
390
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | ILA 1,089.00 | 0.00% | 11 |
| 26-07-16 | ILA 1,089.00 | -0.37% | 1,379 |
| 26-07-15 | ILA 1,093.00 | +6.01% | 1,378 |
| 26-07-14 | ILA 1,031.00 | +0.10% | 7,170 |
| 26-07-13 | ILA 1,030.00 | 0.00% | 11,460 |
- Stock Market
- Stocks
- REKA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
